DenovAI Biotech
DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.
About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does DenovAI Biotech do?
DenovAI Biotech designs bespoke proteins from scratch using artificial intelligence and computational molecular biophysics. Their core offerings include developing next-generation therapeutics like high-affinity antibodies and small protein/peptide biologics, as well as diagnostic reporters. They aim to transform human health by creating foundational technology platforms for de novo protein design.
Where is DenovAI Biotech headquartered?
DenovAI Biotech is headquartered in Rehovot, Israel.
When was DenovAI Biotech founded?
DenovAI Biotech was founded in 2023.
What industry does DenovAI Biotech operate in?
DenovAI Biotech operates in Life Sciences, Biotech, Drug Discovery, AI-Driven Protein Design, Genomics, HealthTech.
How many employees does DenovAI Biotech have?
DenovAI Biotech has approximately 11 people on record.